Red Light Therapy vs. Photobiomodulation: What’s the Difference?

Red light is part of the picture

Red light typically refers to visible wavelengths in the red portion of the spectrum. In PBM research, red and near-infrared ranges are the most established, because photons in these ranges interact with cellular photoacceptors — notably cytochrome c oxidase in mitochondria — and influence cellular signaling. [S2, S3]

That makes red light a legitimate tool. What it does not make is a complete protocol: the same color of light, delivered at a different dose, distance or duration, can produce a different biological response. [S4]

What makes photobiomodulation different?

Photobiomodulation is not “using a stronger light.” It is the controlled delivery of non-thermal light using defined parameters. Reviews of the field consistently emphasize the same variables: wavelength, irradiance (mW/cm²), fluence (J/cm²), pulse structure, exposure time and treatment schedule. [S4, S5]

This is why two devices that emit a similar color cannot be assumed to deliver the same biological dose. A category label says little by itself — the parameters and the evidence behind them say almost everything.

Why multiple wavelengths?

Different wavelengths interact differently with tissue. Shorter red wavelengths are generally used for more superficial targets, while longer near-infrared wavelengths are typically selected when deeper optical penetration is desired — with the caveat that actual penetration depends on tissue properties, geometry, irradiance and distance. [S4]

Laboratory work supports wavelength-specific responses: Karu and colleagues identified action-spectrum maxima around 620, 680, 760 and 820 nm in a cellular model. [S3] For a practice, the practical consequence is flexibility: a system able to select and combine wavelength bands by protocol can address different targets within one platform.